Detalles de la búsqueda
1.
BPI-3016, a novel long-acting hGLP-1 analogue for the treatment of Type 2 diabetes mellitus.
Pharmacol Res
; 122: 130-139, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28619366
2.
A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung Cancer.
Oncologist
; 21(11): 1294-1295d, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27789778
3.
Icotinib, a selective EGF receptor tyrosine kinase inhibitor, for the treatment of non-small-cell lung cancer.
Future Oncol
; 11(3): 385-97, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25675121
4.
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.
Lancet Oncol
; 14(10): 953-61, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23948351
5.
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
Clin Cancer Res
; 29(16): 3151-3161, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363966
6.
Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors.
Bioorg Med Chem Lett
; 22(19): 6301-5, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22959248
7.
Metabolite characterization of a novel anti-cancer agent, icotinib, in humans through liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.
Rapid Commun Mass Spectrom
; 25(15): 2131-40, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21732454
8.
A novel GLP-1 analog, BPI3006, with potent DPP IV resistance and good glucoregulatory effect.
Biochem Biophys Res Commun
; 400(4): 563-8, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20804731
9.
Long-term safety of icotinib in patients with non-small cell lung cancer: a retrospective, real-world study.
J Thorac Dis
; 12(3): 639-650, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274129
10.
What a polyclonal antibody sees in von Willebrand factor.
Thromb Res
; 121(4): 519-26, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-17614124
11.
Efficacy of icotinib in advanced lung squamous cell carcinoma.
Cancer Med
; 7(9): 4456-4466, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30109777
12.
Icotinib inhibits EGFR signaling and alleviates psoriasis-like symptoms in animal models.
Biomed Pharmacother
; 98: 399-405, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29276968
13.
Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1068-1069: 33-40, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29028616
14.
Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China.
Oncotarget
; 8(6): 9996-10006, 2017 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28036283
15.
Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study.
J Thorac Oncol
; 11(6): 910-7, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26980473
16.
Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study.
Lung Cancer
; 96: 93-100, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27133757
17.
Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer.
Lung Cancer
; 89(3): 262-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26162563
18.
A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?
Clin Lung Cancer
; 16(6): e173-81, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25958850
19.
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
PLoS One
; 10(11): e0142500, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26599904
20.
Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjects.
Cancer Chemother Pharmacol
; 73(4): 721-7, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24488324